WHO ICTRP trial
Application of CalliSpheres drug-loaded microspheres combined with PD-1…
ChiCTR2100053624 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100053624 |
|---|---|
| Public title | Application of CalliSpheres drug-loaded microspheres combined with PD-1 inhibitors and antiangiogenic drugs in advanced liver cancer |
| Scientific title | Application of CalliSpheres drug-loaded microspheres combined with PD-1 inhibitors and antiangiogenic drugs in advanced liver cancer |
| Primary sponsor | Zhejiang Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Liver cancer |
| Interventions | Experimental group:D-TACE+PD-1 inhibitors + antiangiogenic drugs;Control group:D-TACE |
| Registration date | Nov 25, 2021 |
| Target size | Experimental group:50;Control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: